Global Drug use Criminal Justice Process Recording of offences (arrests/suspects) Investigation Prosecution Conviction Prison Drug-related crime Over the period 2003-2012, the annual global proportion of drug users that was arrested for possession for personal use has fluctuated between 3 and 4 per cent Cannabis is the most prominent drug in offences for possession for personal use. For trafficking offences, ATS is the prominent drug in Asia and cocaine in the Americas Joint UNODC-UNAIDSWHO-WB estimates People who inject drugs 12.7 million people who inject drugs (0.27 % prevalence) HIV among PWID 1.7 million PWID living with HIV (13.1% of PWID) Opiate seizures Opium cultivation and production Stability of the opiate global market Coca cultivation and production Changes in cannabis market in Europe Cannabis market in the US Changing cannabis policy in the Americas • INCB position • Details, design and implementation of the new laws vary significantly • Need for monitoring and evaluation – Health • Increase in prevalence from recreational use sale expected , but need to look at the health impact and possible substitution effects – Criminal justice • Not easy to assess, there are data on persons apprehended for possession for personal use, but no data to show what happens after in terms of prosecution, conviction and imprisonment – Economic costs and benefits ATS seizures Americas Europe 1990 Source: UNODC estimates based on World Bank, Indicators, August 2013 . Asia 2010 Africa All Oceania - - All Africa - Other Asia 1% 1% 1% 1% 2% 5% 3% 2% 35% 35% 32% 30% 27% 24% 21% 19% 20% East & South-East Asia All Asia Other Europe West & Central Europe All Europe 9% 7% 10% Other Americas 32% 30% 30% North America 37% 40% All Americas 42% Distribution of value-added of chemical industry Regional distribution of the value added of the global chemical industry, 1990-2010 50% 0% Oceania Global exports of the chemical industry, 1990-2012 Growth in exports, output and value-added of the chemical industry (based on constant US$) 10.0% 2,000 Average annual growth in % in billion US dollars 8.7% 1,500 1,000 500 8.0% 5.8% 6.0% 4.0% 3.5% 6.1% 3.3% 2.4% 2.0% in current US dollars in constant 2012 US dollars 2012 2010 2008 2006 2004 2002 2000 1998 1996 1994 1992 1990 0 0.0% Value added 1990-2010 Output Exports 2000-2010 Sources: UNODC estimates based on World Bank Indicators, UNIDO Industrial Database and UN COMTRADE (SITC Rev.3). Potential manufacture of precursor chemicals (Table I and Table II), 2010-2012 20 countries officially reported manufacture of Table I precursors to UNODC over the 2010-2012 period (8 in Asia, 8 in Europe and 4 in the Americas). 77 potential precursors producing countries account for 77% of the world population Sources: UNODC, Annual Reports Questionnaire data and UN COMTRADE data. Global (legal) exports of precursor chemicals in constant 2012 US dollars, 1996-2012 8,000.0 7,000.0 1,800.0 Change: 1996-2012: Table I precursors: +35% Table II precursors: 3½ times 1,600.0 1,400.0 6,000.0 1,200.0 5,000.0 1,000.0 4,000.0 800.0 3,000.0 600.0 2,000.0 400.0 1,000.0 200.0 0.0 0.0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 All internationally controlled precursors (left axis) Table I precursors (right axes) Source: COMTRADE data. Table II precursors (left axes) in million constant 2012 US dollars (Table I precursors) in million constant 2012 US dollars (all precursors and Table II precursors) 9,000.0 Global seizures of Table I precursors, 1989-2012 1,400 Seizures in tons 1,200 1,000 800 600 400 200 Cocaine precursor* Heroin precursor* ATS precursors* Others* Table I substances 3 years average (smoothed) *cocaine precursor: potassium permanganate; heroin precursor: acetic anhydride; amphetamine-type stimulants (ATS) precursors: P-2-P, phenylacetic acid, ephedrine, pseudoephedrine, norephedrine, 3,4-MDP-2-P, safrole, isosafrole, piperonal; others: lysergic acid; ergometrine, ergotamine, N-Aceylanthranilic acid *preliminary data for 2012; data may still rise once additional information becomes available. Source: INCB, 2013 Precursors report, New York 2014 (and previous years). Effects of precursor control • Seizures and stopped shipments • Seizures of Table I precursors: 12-fold increase 1990-92 and 2010-2012 • Stopped precursors shipments even more important than precursors seizures • Additional measurements of ‘effectiveness’: – Interception rate (15% for diverted potassium permanganate and acetic anhydride over the 2007-2012 period) – Reduction of drug availability • Seizures of precursor chemicals compared to drug seizures Seizures of ecstasy precursors: 18% more than ecstasy seizures (2007-2012); Seizures of amphetamines precursors: > 2-fold seizures of amphetamine and methamphetamine (2007-2012) • Cases of reductions in supply of drugs linked to precursors control: LSD, methaqualone, ecstasy – Impact of precursor control on prices: Licit: $1-1.5 per litre of acetic anhydride; Afghanistan: $8 in 2002; ≈ $200 ($157-$221) in 2013 Reactions of clandestine operators • More sophisticated ways to obtain precursor chemicals – – – – – Creation of specialized groups to obtain the precursors chemicals Creation of front companies Identification of weak links in the control system Identification of weaknesses at the national level (diversion from domestic sources) Use of the Internet • Use of pharmaceutical preparations (containing ephedrine and pseudoephedrine) • Use of substitute chemicals and pre-precursors (APAAN, esters of phenylacete (ethyl phenylacete, methyl phenylacetate), 3,4-MDP-2-P methyl glycidate, methylamine, etc.) • Production of New Psychoactive Substances (NPS) Conclusions • Potential vulnerabilities of diversion of precursor chemicals increased over the last two decades • Nonetheless, progress has been made in precursor control since the 1988 Convention was adopted • Challenges are arising from new strategies adopted by operators of clandestine laboratories, notably the use of non-controlled ‘substitute precursors‘ • Some of the instruments (international legal requirements) already exist: – ‘limited international special surveillance list’ – diversion of non-scheduled substances for clandestine manufacture made a ‘criminal offence’ – pre-export notifications for non-scheduled substances and pharmaceutical preparations – participation in the PICS, including for non-scheduled substances • … but are still awaiting global implementation THANK YOU FOR YOUR ATTENTION For more information: http://www.unodc.org/